Advertisement
UK markets close in 48 minutes
  • FTSE 100

    8,066.32
    +25.94 (+0.32%)
     
  • FTSE 250

    19,599.84
    -119.53 (-0.61%)
     
  • AIM

    752.70
    -1.99 (-0.26%)
     
  • GBP/EUR

    1.1660
    +0.0016 (+0.13%)
     
  • GBP/USD

    1.2494
    +0.0031 (+0.25%)
     
  • Bitcoin GBP

    50,798.93
    -1,196.73 (-2.30%)
     
  • CMC Crypto 200

    1,379.54
    -3.04 (-0.22%)
     
  • S&P 500

    5,000.07
    -71.56 (-1.41%)
     
  • DOW

    37,768.52
    -692.40 (-1.80%)
     
  • CRUDE OIL

    82.27
    -0.54 (-0.65%)
     
  • GOLD FUTURES

    2,342.90
    +4.50 (+0.19%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,877.02
    -211.68 (-1.17%)
     
  • CAC 40

    7,996.46
    -95.40 (-1.18%)
     

Is Now The Time To Look At Buying IXICO plc (LON:IXI)?

IXICO plc (LON:IXI), might not be a large cap stock, but it saw significant share price movement during recent months on the AIM, rising to highs of UK£0.84 and falling to the lows of UK£0.68. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether IXICO's current trading price of UK£0.71 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at IXICO’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

Check out our latest analysis for IXICO

Is IXICO still cheap?

Great news for investors – IXICO is still trading at a fairly cheap price according to my price multiple model, where I compare the company's price-to-earnings ratio to the industry average. In this instance, I’ve used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock’s cash flows. I find that IXICO’s ratio of 26.1x is below its peer average of 54.56x, which indicates the stock is trading at a lower price compared to the Life Sciences industry. Another thing to keep in mind is that IXICO’s share price is quite stable relative to the rest of the market, as indicated by its low beta. This means that if you believe the current share price should move towards its industry peers, a low beta could suggest it is not likely to reach that level anytime soon, and once it’s there, it may be hard to fall back down into an attractive buying range again.

What does the future of IXICO look like?

earnings-and-revenue-growth
earnings-and-revenue-growth

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. Though in the case of IXICO, it is expected to deliver a highly negative earnings growth in the upcoming, which doesn’t help build up its investment thesis. It appears that risk of future uncertainty is high, at least in the near term.

What this means for you:

Are you a shareholder? Although IXI is currently trading below the industry PE ratio, the negative profit outlook does bring on some uncertainty, which equates to higher risk. I recommend you think about whether you want to increase your portfolio exposure to IXI, or whether diversifying into another stock may be a better move for your total risk and return.

ADVERTISEMENT

Are you a potential investor? If you’ve been keeping tabs on IXI for some time, but hesitant on making the leap, I recommend you dig deeper into the stock. Given its current price multiple, now is a great time to make a decision. But keep in mind the risks that come with negative growth prospects in the future.

If you want to dive deeper into IXICO, you'd also look into what risks it is currently facing. Our analysis shows 4 warning signs for IXICO (2 are a bit unpleasant!) and we strongly recommend you look at them before investing.

If you are no longer interested in IXICO, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.